Multiple Sclerosis (MS) is a disabling disease in which the immune system attacks the nervous system. The cause of MS is unknown and no treatments as yet exist that can cure the disease or least, stop disability progression. This study will use an animal model of MS to determine if angiotensin (1-7) is a sutable candidate therapy to alleviate the symptoms and progression of MS; findings from this study will also give an indication of the suitability of this treatment in other nervous system disorders.

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.